Increased levels of SAP30BP have been demonstrated to be present in synovial cells in rheumatoid arthritis (RA) patients, which indicates that SAP30BP may promote the death of related cells or some cytokines in patients with RA, preventing the prompt activation of certain immune pathways [21]. This evidence concerns the gene SAP30BP and rheumatoid arthritis.